Gene · 60485
Papers1,483
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,483
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies. | Front Oncol | 2023 | 37469419 | PubTator, text mining | PubMed |
| PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling. | Cell Death Dis | 2023 | 37454211 | PubTator, text mining | PubMed |
| The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment. | Cancers (Basel) | 2023 | 37444578 | PubTator, text mining | PubMed |
| Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies. | MedComm (2020) | 2023 | 37441462 | PubTator, text mining | PubMed |
| Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma. | Front Toxicol | 2023 | 37441092 | PubTator, text mining | PubMed |
| Mechanical Properties of Glioblastoma: Perspectives for YAP/TAZ Signaling Pathway and Beyond. | Diseases | 2023 | 37366874 | PubTator, text mining | PubMed |
| Inhibition of TAZ impairs the migration ability of melanoma cells. | Open Life Sci | 2023 | 37360787 | PubTator, text mining | PubMed |
| A comprehensive review of stroke-related signaling pathways and treatment in western medicine and traditional Chinese medicine. | Front Neurosci | 2023 | 37351420 | PubTator, text mining | PubMed |
| Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1. | Cell Commun Signal | 2023 | 37337213 | PubTator, text mining | PubMed |
| The role of Hippo pathway in ovarian development. | Front Physiol | 2023 | 37334049 | PubTator, text mining | PubMed |
| Chaetocin exhibits anticancer effects in esophageal squamous cell carcinoma via activation of Hippo pathway. | Aging (Albany NY) | 2023 | 37319316 | PubTator, text mining | PubMed |
| Signaling pathways and intervention for therapy of type 2 diabetes mellitus. | MedComm (2020) | 2023 | 37303813 | PubTator, text mining | PubMed |
| Current Model Systems for Investigating Epithelioid Haemangioendothelioma. | Cancers (Basel) | 2023 | 37296967 | PubTator, text mining | PubMed |
| Genome-Wide Screening in Human Embryonic Stem Cells Highlights the Hippo Signaling Pathway as Granting Synthetic Viability in ATM Deficiency. | Cells | 2023 | 37296624 | PubTator, text mining | PubMed |
| The relationship between the Hippo signaling pathway and bone metastasis of breast cancer. | Front Oncol | 2023 | 37256184 | PubTator, text mining | PubMed |
| Cadherins and catenins in cancer: connecting cancer pathways and tumor microenvironment. | Front Cell Dev Biol | 2023 | 37255594 | PubTator, text mining | PubMed |
| Epigenome-wide DNA methylation analysis of myasthenia gravis. | FEBS Open Bio | 2023 | 37254650 | PubTator, text mining | PubMed |
| The hippo kinases MST1/2 in cardiovascular and metabolic diseases: A promising therapeutic target option for pharmacotherapy. | Acta Pharm Sin B | 2023 | 37250161 | PubTator, text mining | PubMed |
| LncRNA FAM83A-AS1 promotes epithelial-mesenchymal transition of pancreatic cancer cells via Hippo pathway. | Cell Cycle | 2023 | 37245082 | PubTator, text mining | PubMed |
| Activating the Hippo pathway by nevadensin overcomes Yap-drived resistance to sorafenib in hepatocellular carcinoma. | Discov Oncol | 2023 | 37243813 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/60485/papers?page=7